Ikechebelu J I, Ugboaja J O, Kalu S O, Ugochukwu E F
PMTCT Laboratory Unit of Institute of Human Virology Nigeria, Nnamdi Azikiwe University Teaching Hospital Nnewi, Nigeria.
Niger J Med. 2011 Oct-Dec;20(4):421-5.
A lot of challenges face the current efforts at reducing Mother to Child transmission of HIV infection (MTCT) in Sub Saharan Africa due to limited access to Highly active antiretroviral therapy (HAART) and breast feeding practices. A regular review of progress is necessary in order to identify areas of need.
This is a one year prospective descriptive study of seven hundred and twenty six mother-infant pairs managed in the PMTCT programme in Nnamdi Azikiwe University Teaching Hospital, Nnewi Southeast Nigeria. The babies HIV status was tested with PCR for HIV DNA while the mothers provided information on infant feeding pattern and the use of antiretroviral (ARV) drugs including prophylaxis for the baby. Information was augmented from the antenatal records.
The transmission rate was 2.8% for mothers, who were on HAART, did not breastfeed and whose babies received ARV prophylactic therapy. But for mothers who did not receive HAART, did breastfeed and whose babies did not received ARV prophylactic therapy, the transmission rate was 37.5%. When both the mother and child received ARV drugs, the transmission rate was significantly lower in those who did not breastfeed (2.8%) than in those who breastfed (12.5%)(P < 0.001). When both the mother and child did not receive ARV drugs, the transmission rate significantly lower in those who did not breastfeed (21.1%)than in those who breastfed (37.5%) (P < 0.02).
The use of HAART in PMTCT programme in the under resourced areas can achieve similar success rates to that in the industrialized countries. Breastfeeding reduces the efficacy achieved by the use of ARV drugs. Provision of wider access to HAART as well as adequate counselling and support for safer infant feeding practices is recommended.
由于获得高效抗逆转录病毒疗法(HAART)的机会有限以及母乳喂养习惯,撒哈拉以南非洲地区目前在减少母婴传播艾滋病毒感染(MTCT)方面面临诸多挑战。定期审查进展情况对于确定需求领域很有必要。
这是一项为期一年的前瞻性描述性研究,研究对象为尼日利亚东南部Nnewi的纳姆迪·阿齐克韦大学教学医院PMTCT项目中管理的726对母婴。采用聚合酶链反应(PCR)检测婴儿的艾滋病毒DNA状态,同时母亲提供有关婴儿喂养方式以及使用抗逆转录病毒(ARV)药物(包括给婴儿的预防性用药)的信息。从产前记录中补充信息。
接受HAART、不进行母乳喂养且婴儿接受ARV预防性治疗的母亲,其传播率为2.8%。但对于未接受HAART、进行母乳喂养且婴儿未接受ARV预防性治疗的母亲,传播率为37.5%。当母亲和孩子都接受ARV药物治疗时,不进行母乳喂养的母亲的传播率(2.8%)显著低于进行母乳喂养的母亲(12.5%)(P<0.001)。当母亲和孩子都未接受ARV药物治疗时,不进行母乳喂养的母亲的传播率(21.1%)显著低于进行母乳喂养的母亲(37.5%)(P<0.02)。
在资源匮乏地区的PMTCT项目中使用HAART可取得与工业化国家相似的成功率。母乳喂养会降低ARV药物的疗效。建议提供更广泛的HAART获取途径以及对更安全的婴儿喂养方式进行充分的咨询和支持。